Effects of aminoglutethimide on hypothalamic-pituitary-adrenal functions.
This study was performed on four groups of subjects, including 10 patients with Cushing's disease, 10 patients with simple obesity, 8 patients with hypopituitarism and 13 normal subjects. The study was conducted by measuring the sequential changes of plasma ACTH, serum cortisol, 24-h UFC, 24-h 17 KS and 24-h 17 KGS following aminoglutethimide (AG) administration. The results suggest that normal subjects showed sequential changes of hypothalamic-pituitary-adrenal hormone concentrations with normal feedback regulation of the axis following AG administration. Patients with Cushing's disease had obvious autonomy in the production of ACTH from the pituitary. Patients with simple obesity might display abnormality to some degree in the production from the pituitary. Patients with hypopituitarism lost the capacity of ACTH production in various degrees because of pituitary lesions.
Pan
C Y
CY
Luo
G C
GC
Li
J Y
JY
Wang
Y Z
YZ
Lu
S Z
SZ
Ma
S Q
SQ
Guo
A Y
AY
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000616:Aminoglutethimide / Q000494:pharmacology* / Q000627:therapeutic use; D002648:Child; D003480:Cushing Syndrome / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007018:Hypopituitarism / Q000188:drug therapy / Q000503:physiopathology; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy; D010913:Pituitary-Adrenal System / Q000187:drug effects*
D000616:Aminoglutethimide; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone